BIODEXA PHARMACEUTICALS-ADR (BDRX)

US59564R7089 - ADR

1.11  +0.01 (+0.91%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
381.00K699.00K578.00K343.00K674.00K
Operating Expenses
8.39M9.63M7.58M11.01M11.99M
Research and Development
4.07M5.11M4.65M6.07M7.84M
Selling, General, and Administrative Expenses
4.34M4.54M2.95M4.96M4.16M
Operating Income
-8.01M-8.93M-7.00M-10.67M-11.32M
Interest Income/Expense
519.00K444.00K892.00K-430.00K395.00K
Other Income/Expense
10.00KN/AN/AN/AN/A
Non Recurring Items
N/A0.000.00-12.37M0.00
Income Before Taxes
-7.49M-8.49M-6.11M-23.47M-10.92M
Income Tax
-406.00K-832.00K-646.00K-1.28M-1.78M
Net Income
-7.08M-7.66M-5.46M-22.19M-10.09M
EBITDA
-7.73M-8.59M-6.59M-9.45M-10.03M
 
Per Share Data
EPS Diluted Total Ops
-1.61-111.59-7.81K-59.70K-792.33
 
Statistics
Profit Margin
-1858.01%-1095.28%-944.64%-6469.10%-1496.29%
Operating Profit Margin
-2103.41%-1277.83%-1210.73%-3111.08%-1679.23%

All data in GBP

Charts